Safety and immunogenicity of GamEvac-Combi, a heterologous VSV- and Ad5-vectored Ebola vaccine: An open phase I/II trial in healthy adults in Russia-Reference-Cited by-同舟云学术

Safety and immunogenicity of GamEvac-Combi, a heterologous VSV- and Ad5-vectored Ebola vaccine: An open phase I/II trial in healthy adults in Russia

Published:2017-02-02 Issue:3 Volume:13 Page:613-620
ISSN:2164-5515
Container-title:Human Vaccines & Immunotherapeutics
language:en
Short-container-title:Human Vaccines & Immunotherapeutics

Author:

Dolzhikova I. V.¹,Zubkova O. V.¹,Tukhvatulin A. I.¹,Dzharullaeva A. S.¹,Tukhvatulina N. M.¹,Shcheblyakov D. V.¹,Shmarov M. M.¹,Tokarskaya E. A.¹,Simakova Y. V.¹,Egorova D. A.¹,Scherbinin D. N.¹,Tutykhina I. L.¹,Lysenko A. A.¹,Kostarnoy A. V.¹,Gancheva P. G.¹,Ozharovskaya T. A.¹,Belugin B. V.¹,Kolobukhina L. V.¹,Pantyukhov V. B.²,Syromyatnikova S. I.²,Shatokhina I. V.²,Sizikova T. V.²,Rumyantseva I. G.²,Andrus A. F.²,Boyarskaya N. V.²,Voytyuk A. N.²,Babira V. F.³,Volchikhina S. V.³,Kutaev D. A.²,Bel'skih A. N.⁴,Zhdanov K. V.⁴,Zakharenko S. M.⁴,Borisevich S. V.²,Logunov D. Y.¹,Naroditsky B. S.¹,Gintsburg A. L.¹

Affiliation:

1. Federal Research Centre of Epidemiology and Microbiology named after Honorary Academician N. F. Gamaleya, Ministry of Health, Moscow, Russia

2. 48 Central Research Institute, Ministry of Defense, Sergiev Posad-6, Russia

3. No. 7 Main Military Clinical Hospital named after academician N. N. Burdenko, Ministry of Defense, Posad-7, Russia

4. Military Medical Academy named after S. M. Kirov, Ministry of Defense, Saint Petersburg, Russia

Publisher

Informa UK Limited

Subject

Pharmacology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/21645515.2016.1238535

Reference23 articles.